Is There a Relation between Adenosine and Caffeines’ Mechanisms of Action and Toll-Like Receptor-4 (TLR-4)?
- 1 Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
- 2 Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
- 3 Department of Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
- 4 Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
Abstract
Previous studies showed that endogenous adenosine, an anti-inflammatory agent, was released at sites of injury and inflammation thereby decreasing the excessive production of pro-inflammatory cytokines. Caffeine, a non-specific adenosine blocker, has been reported in several studies to have opposing immune-modulatory effects. In this study, the effects of caffeine and adenosine on TLR-4 in promoting or decreasing the production of TNF-α and IL-12 by LPS-stimulated monocytes were investigated. Monocytes were isolated using Pluribead<sup> ® </sup> kit from pooled blood obtained from ten volunteers. The monocytes were then incubated for 24 hours with Lipopolysaccharide (pLPS) extracted from Escherichia coli (aTLR-4 ligand activator), adenosine, caffeine and LPS extracted from <i>Rhodobacter sphaeroides</i> (LPS-RS, a TLR-4 ligand blocker), each alone or in different combinations. Later, the levels of pro-inflammatory cytokines TNF<i>α</i> and IL-12 were assessed in supernatants using an Enzyme Linked Immuno Assay (ELISA). Caffeine and adenosine significantly reduced the amount of TNF<i>α</i> and IL-12 produced by LPS-stimulated monocytes. Regarding non-stimulated and LPS-RS blocked monocytes, the presence of adenosine and caffeine significantly decreased TNFα levels produced by these cells but had little or non-significant effect on the levels of IL-12. In conclusion, both caffeine and adenosine blocked the production of the pro-inflammatory cytokines by pLPS-stimulated-monocytes. TLR-4 did not appear to be involved in the signaling pathway of caffeine and adenosine since blocking of TLR-4 did not abolish the effects of adenosine and caffeine on production of cytokines, in particular TNF-<i>α</i>.
- Alexander, C. and Rietschel, E.T. (2001) Invited Review: Bacterial Lipopolysaccharides and Innate Immunity. Journal of Endotoxin Research, 7, 167-202. http://dx.doi.org/10.1177/09680519010070030101
- Fujihara, M., Muroi, M., Tanamoto, K.I., Suzuki, T., Azuma, H. and Ikeda, H. (2003) Molecular Mechanisms of Macrophage Activation and Deactivation by Lipopolysaccharide: Roles of the Receptor Complex. Pharmacology & Therapeutics, 100, 171-194. http://dx.doi.org/10.1016/j.pharmthera.2003.08.003
- Park, B.S. and Lee, J.O. (2013) Recognition of Lipopolysaccharide Pattern by TLR4 Complexes. Experimental & Molecular Medicine, 45, e66. http://dx.doi.org/10.1038/emm.2013.97
- Bryant, C.E., Spring, D.R., Gangloff, M. and Gay, N.J. (2010) The Molecular Basis of the Host Response to Lipopolysaccharide. Nature Reviews Microbiology, 8, 8-14.
- Liaunardy-Jopeace, A. and Gay, N.J. (2014) Molecular and Cellular Regulation of Toll-Like Receptor-4 Activity Induced by Lipopolysaccharide Ligands. Frontiers in Immunology, 5, 473. http://dx.doi.org/10.3389/fimmu.2014.00473
- Teghanemt, A., Zhang, D., Levis, E.N., Weiss, J.P. and Gioannini, T.L. (2005) Molecular Basis of Reduced Potency of Underacylated Endotoxins. The Journal of Immunology, 175, 4669-4676. http://dx.doi.org/10.4049/jimmunol.175.7.4669
- Coats, S.R., Pham, T.T.T., Bainbridge, B.W., Reife, R.A. and Darveau, R.P. (2005) MD-2 Mediates the Ability of Tetra-Acylated and Penta-Acylated Lipopolysaccharides to Antagonize Escherichia coli Lipopolysaccharide at the TLR4 Signaling Complex. The Journal of Immunology, 175, 4490-4498. http://dx.doi.org/10.4049/jimmunol.175.7.4490
- Haskó, G. and Cronstein, B.N. (2004) Adenosine: An Endogenous Regulator of Innate Immunity. Trends in Immunology, 25, 33-39. http://dx.doi.org/10.1016/j.it.2003.11.003
- Haskó, G., Linden, J., Cronstein, B. and Pacher, P. (2008) Adenosine Receptors: Therapeutic Aspects for Inflammatory and Immune Diseases. Nature Reviews Drug Discovery, 7, 759-770. http://dx.doi.org/10.1038/nrd2638
- McNeill, B.W. (2004) Adenosine Receptor Mediated Inhibition of Tumor Necrosis Factor Alpha in Human Monocytic Cells. Doctoral Dissertation, University of Georgia.
- McColl, S.R., St-Onge, M., Dussault, A.A., Laflamme, C., Bouchard, L., Boulanger, J. and Pouliot, M. (2006) Immunomodulatory Impact of the A2A Adenosine Receptor on the Profile of Chemokines Produced by Neutrophils. The FASEB Journal, 20, 187-189.